Protective Effects of catechin against monosodium urate-induced inflammation through the modulation of NLRP3 inflammasome activation

Journal of Agricultural and Food Chemistry

Volumn 63, Issue 33, 2015, Pages 7343-7352

  Jhang, Jhih Jia ^a   Lu, Chi Cheng ^a   Ho, Cheng Ying ^a   Cheng, Yu Ting ^a   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Catechin; IL 1 ; Inflammation; Monosodium urate; NLRP3

Indexed keywords

BIOELECTRIC POTENTIALS; CHEMICAL ACTIVATION; FLAVONOIDS; FREE RADICALS; MODULATION; ORGANIC COMPOUNDS; PATHOLOGY; PHYSIOLOGY;

CATECHIN; FREE RADICAL SCAVENGING ACTIVITY; INFLAMMATION; INTRACELLULAR CALCIUM LEVELS; MITOCHONDRIAL TRANSMEMBRANE POTENTIALS; MONOSODIUM URATE; NLRP3; REACTIVE OXYGEN SPECIES;

PHENOLS;

CALCIUM; CARRIER PROTEIN; CATECHIN; CIAS1 PROTEIN, MOUSE; GALLIC ACID; INFLAMMASOME; INTERLEUKIN 1BETA; PROTECTIVE AGENT; SCAVENGER; URIC ACID;

ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; MALE; METABOLISM; OXIDATIVE STRESS; PERITONITIS;

ANIMALS; CALCIUM; CARRIER PROTEINS; CATECHIN; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; GALLIC ACID; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MICE, INBRED C57BL; OXIDATIVE STRESS; PERITONITIS; PROTECTIVE AGENTS; URIC ACID;

EID: 84940555595     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b02605     Document Type: Article

References (44)

1. Choi, H. K.; Mount, D. B.; Reginato, A. M. Pathogenesis of gout. Ann. Intern. Med. 2005, 143, 499-516.
2. Cronstein, B. N.; Terkeltaub, R. The inflammatory process of gout and its treatment. Arthritis Res. Ther. 2006, 8, S3.
3. Terkeltaub, R. Gout. Novel therapies for treatment of gout and hyperuricemia. Arthritis Res. Ther. 2009, 11, 236.
4. Stamp, L. K.; O'Donnell, J. L.; Chapman, P. T. Emerging therapies in the long-term management of hyperuricaemia and gout. Intern. Med. J. 2007, 37, 258-266.
5. Burns, C. M.; Wortmann, R. L. Gout therapeutics: new drugs for an old disease. Lancet 2011, 377, 165-177.
6. Martinon, F.; Petrilli, V.; Mayor, A.; Tardivel, A.; Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440, 237-241.
7. Martinon, F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol. Rev. 2010, 233, 218-232.
8. Tschopp, J.; Schroder, K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 2010, 10, 210-215.
9. Zhou, R.; Tardivel, A.; Thorens, B.; Choi, I.; Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11, 136-140.
10. Zhou, R.; Yazdi, A. S.; Menu, P.; Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469, 221-225.
11. Dostert, C.; Petrilli, V.; Van Bruggen, R.; Steele, C.; Mossman, B. T.; Tschopp, J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320, 674-677.
12. Rahman, I.; Biswas, S. K.; Kirkham, P. A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 2006, 72, 1439-1452.
13. Tsai, P. Y.; Ka, S. M.; Chang, J. M.; Chen, H. C.; Shui, H. A.; Li, C. Y.; Hua, K. F.; Chang, W. L.; Huang, J. J.; Yang, S. S.; Chen, A. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radical Biol. Med. 2011, 51, 744-754.
14. Wang, C.; Pan, Y.; Zhang, Q. Y.; Wang, F. M.; Kong, L. D. Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One 2012, 7, e38285.
15. Chuang, S. Y.; Lin, C. H.; Fang, J. Y. Natural compounds and aging: between autophagy and inflammasome. BioMed Res. Int. 2014, 2014, 297293.
16. Orallo, F.; Alvarez, E.; Camina, M.; Leiro, J. M.; Gomez, E.; Fernandez, P. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 2002, 61, 294-302.
17. Martin, W. J.; Walton, M.; Harper, J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum. 2009, 60, 281-289.
18. Jhang, J. J.; Cheng, Y. T.; Ho, C. Y.; Yen, G. C. Monosodium urate crystals trigger Nrf2- and heme oxygenase-1-dependent inflammation in THP-1 cells. Cell. Mol. Immunol. 2015, 12, 424-434.
19. Hornung, V.; Bauernfeind, F.; Halle, A.; Samstad, E. O.; Kono, H.; Rock, K. L.; Fitzgerald, K. A.; Latz, E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9, 847-856.
20. Im, J. Y.; Lee, K. W.; Woo, J. M.; Junn, E.; Mouradian, M. M. DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum. Mol. Genet. 2012, 21, 3013-3024.
21. Murakami, T.; Ockinger, J.; Yu, J.; Byles, V.; McColl, A.; Hofer, A. M.; Horng, T. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 11282-11287.
22. Lee, G. S.; Subramanian, N.; Kim, A. I.; Aksentijevich, I.; Goldbach-Mansky, R.; Sacks, D. B.; Germain, R. N.; Kastner, D. L.; Chae, J. J. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 2012, 492, 123-127.
23. Shimada, K.; Crother, T. R.; Karlin, J.; Dagvadorj, J.; Chiba, N.; Chen, S.; Ramanujan, V. K.; Wolf, A. J.; Vergnes, L.; Ojcius, D. M.; Rentsendorj, A.; Vargas, M.; Guerrero, C.; Wang, Y.; Fitzgerald, K. A.; Underhill, D. M.; Town, T.; Arditi, M. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36, 401-414.
24. Masuoka, N.; Nihei, K.; Kubo, I. Xanthine oxidase inhibitory activity of alkyl gallates. Mol. Nutr. Food Res. 2006, 50, 725-731.
25. Cos, P.; Ying, L.; Calomme, M.; Hu, J. P.; Cimanga, K.; Van Poel, B.; Pieters, L.; Vlietinck, A. J.; Vanden Berghe, D. Structureactivity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Nat. Prod. 1998, 61, 71-76.
26. Yilmaz, Y.; Toledo, R. T. Major flavonoids in grape seeds and skins: antioxidant capacity of catechin, epicatechin, and gallic acid. J. Agric. Food Chem. 2004, 52, 255-260.
27. Popa-Nita, O.; Naccache, P. H. Crystal-induced neutrophil activation. Immunol. Cell Biol. 2010, 88, 32-40.
28. Kim, S. H.; Jun, C. D.; Suk, K.; Choi, B. J.; Lim, H.; Park, S.; Lee, S. H.; Shin, H. Y.; Kim, D. K.; Shin, T. Y. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol. Sci. 2006, 91, 123-131.
29. Murase, T.; Kume, N.; Hase, T.; Shibuya, Y.; Nishizawa, Y.; Tokimitsu, I.; Kita, T. Gallates inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler., Thromb., Vasc. Biol. 1999, 19, 1412-1420.
30. Bauernfeind, F.; Bartok, E.; Rieger, A.; Franchi, L.; Nunez, G.; Hornung, V. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J. Immunol. 2011, 187, 613-617.
31. Nakahira, K.; Haspel, J. A.; Rathinam, V. A.; Lee, S. J.; Dolinay, T.; Lam, H. C.; Englert, J. A.; Rabinovitch, M.; Cernadas, M.; Kim, H. P.; Fitzgerald, K. A.; Ryter, S. W.; Choi, A. M. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12, 222-230.
32. McCubrey, J. A.; Steelman, L. S.; Chappell, W. H.; Abrams, S. L.; Wong, E. W.; Chang, F.; Lehmann, B.; Terrian, D. M.; Milella, M.; Tafuri, A.; Stivala, F.; Libra, M.; Basecke, J.; Evangelisti, C.; Martelli, A. M.; Franklin, R. A. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta, Mol. Cell Res. 2007, 1773, 1263-1284.
33. Canet-Aviles, R. M.; Wilson, M. A.; Miller, D. W.; Ahmad, R.; McLendon, C.; Bandyopadhyay, S.; Baptista, M. J.; Ringe, D.; Petsko, G. A.; Cookson, M. R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 9103-9108.
34. Yang, J. C.; Yang, H. C.; Shun, C. T.; Wang, T. H.; Chien, C. T.; Kao, J. Y. Catechins and Sialic Acid Attenuate Helicobacter pylori- Triggered Epithelial Caspase-1 Activity and Eradicate Helicobacter pylori Infection. Evid. Based Complement Alternat. Med. 2013, 2013, 248585.
35. Ellis, L. Z.; Liu, W.; Luo, Y.; Okamoto, M.; Qu, D.; Dunn, J. H.; Fujita, M. Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1beta secretion. Biochem. Biophys. Res. Commun. 2011, 414, 551-556.
36. Neilson, A. P.; Ferruzzi, M. G. Influence of formulation and processing on absorption and metabolism of flavan-3-ols from tea and cocoa. Annu. Rev. Food Sci. Technol. 2011, 2, 125-151.
37. Zhu, M.; Chen, Y.; Li, R. C. Oral absorption and bioavailability of tea catechins. Planta Med. 2000, 66, 444-447.
38. Chia, E. W.; Grainger, R.; Harper, J. L. Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine. Br. J. Pharmacol. 2008, 153, 1288-1295.
39. Martin, W. J.; Herst, P. M.; Chia, E. W.; Harper, J. L. Sesquiterpene dialdehydes inhibit MSU crystal-induced superoxide production by infiltrating neutrophils in an in vivo model of gouty inflammation. Free Radical Biol. Med. 2009, 47, 616-621.
40. Chen, H.; Zheng, S.; Wang, Y.; Zhu, H.; Liu, Q.; Xue, Y.; Qiu, J.; Zou, H.; Zhu, X. The effect of resveratrol on the recurrent attacks of gouty arthritis. Clin. Rheumatol. 2014, DOI: 10.1007/s10067-014-2836-3.
41. Yao, X.; Ding, Z.; Xia, Y.; Wei, Z.; Luo, Y.; Feleder, C.; Dai, Y. Inhibition of monosodium urate crystal-induced inflammation by scopoletin and underlying mechanisms. Int. Immunopharmacol. 2012, 14, 454-462.
42. Wechalekar, M. D.; Vinik, O.; Schlesinger, N.; Buchbinder, R. Intra-articular glucocorticoids for acute gout. Cochrane Database Syst. Rev. 2013, 4, CD009920.
43. Zaveri, N. T. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci. 2006, 78, 2073-2080.
44. Clifford, M. N.; van der Hooft, J. J.; Crozier, A. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. Am. J. Clin. Nutr. 2013, 98, 1619S-1630S.